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The phosphoprotein, P, of vesicular stomatitis virus (VSV) is a key subunit of the viral RNA-dependent RNA
polymerase complex. The protein is phosphorylated at multiple sites in two different domains. We recently
showed that specific serine and threonine residues within the amino-terminal acidic domain I of P protein must
be phosphorylated for in vivo transcription activity, but not for replication activity, of the polymerase complex.
To examine the role of phosphorylation of the carboxy-terminal domain II residues of the P protein in
transcription and replication, we have used a panel of mutant P proteins in which the phosphate acceptor sites
(Ser-226, Ser-227, and Ser-233) were altered to alanines either individually or in various combinations.
Analyses of the mutant proteins for their ability to support replication of a VSV minigenomic RNA suggest that
phosphorylation of either Ser-226 or Ser-227 is necessary for optimal replication activity of the protein. The
mutant protein (P226/227) in which both of these residues were altered to alanines was only about 8% active in
replication compared to the wild-type (wt) protein. Substitution of alanine for Ser-233 did not have any adverse
effect on replication activity of the protein. In contrast, all the mutant proteins showed activities similar to that
of the wt protein in transcription. These results indicate that phosphorylation of the carboxy-terminal domain
II residues of P protein are required for optimal replication activity but not for transcription activity.
Furthermore, substitution of glutamic acid residues for Ser-226 and Ser-227 resulted in a protein that was only
14% active in replication but almost fully active in transcription. Taken together, these results, along with our
earlier studies, suggest that phosphorylation of residues at two different domains in the P protein regulates its
activity in transcription and replication of the VSV genome.
The RNA-dependent RNA polymerase of the prototypic
rhabdovirus, vesicular stomatitis virus (VSV), is comprised of
two virally encoded proteins: the large protein, L, and the
phosphoprotein, P (1, 18, 20). A complex containing both the
L and P proteins carries out transcription and replication of
the viral genome (see reference 1 for a review). The template
recognized by the RNA polymerase complex is the viral nu-
cleocapsid, which contains the ;11-kb-long negative-sense
genomic RNA surrounded by the viral RNA-binding nucleo-
capsid protein, N. During transcription, the nucleocapsid tem-
plate is utilized by the RNA polymerase complex to generate
subgenomic, capped, and polyadenylated mRNAs, which are
translated to produce the viral proteins. During replication, the
same RNA polymerase is believed to be switched from tran-
scriptive to replicative mode to synthesize a full-length, posi-
tive-sense complementary RNA (or antigenomic RNA) encap-
sidated by the N protein, which serves as the template for
synthesis of progeny nucleocapsids.
Biochemical and mutational studies have suggested that the
L protein is multifunctional and carries the catalytic center for
polymerization of ribonucleotides during RNA synthesis (50,
51). It presumably also carries other enzymatic activities, in-
cluding methyltransferase, guanylyltransferase, and poly-
(A)polymerase activities necessary for generation of mature
viral mRNAs (27–29, 32). The multifunctional P protein, on
the other hand, is required for the manifestation of the func-
tions of the L protein (1) and plays key roles in both transcrip-
tion and replication of the viral genome. It interacts specifically
with the L protein to form the polymerase complex of the
virion (21) as well as stabilizing the L protein against proteo-
lytic degradation (9). It interacts with the terminal sequences
of the viral genome (33, 34), presumably for viral RNA syn-
thesis. The P protein also interacts with the N protein to form
soluble N-P complexes required for encapsidation of nascent
RNA chains during replication (36, 48). Furthermore, P inter-
acts with itself to form oligomers that are required for tran-
scription (15, 23, 24).
The P proteins of both the Indiana (PI) and New Jersey
(PNJ) serotypes of VSV are highly acidic and consist of 265 and
274 amino acids, respectively. Although these two proteins
have only 30% similarity at the primary sequence level, three
functionally homologous domains (Fig. 1A) have been defined
in mutational studies (25, 47). Domain I, spanning residues
from 1 to about 150, is the amino-terminal acidic domain and
is phosphorylated. Domain II spans from residues 210 to about
244 and is also phosphorylated. Domain III consists of 21 to 25
residues at the extreme carboxy terminus of the protein and is
highly basic. Between domains I and II, a hypervariable region
(called the hinge) of approximately 50 to 60 amino acids is
present, but its function is unknown.
In the virion core as well as in infected cells, different phos-
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phorylated forms of the P protein have been shown to exist (6,
13, 30, 31). Furthermore, functional P proteins with different
degrees of phosphorylation have been documented (10, 35, 41,
49). It has been shown that the unphosphorylated form of P
protein is inactive in transcription in vitro (2, 3). However, it
becomes transcriptionally active when first phosphorylated by
cellular casein kinase II (CKII) (3, 4, 15). The acceptor sites for
CKII-mediated phosphorylation have been mapped to Ser-60,
Thr-62, and Ser-64 in domain I of PI (12, 52) and Ser-59 and
Ser-61 of PNJ (53). Phosphorylation of these residues was re-
cently shown to mediate the multimerization of P protein that
facilitates complex formation with the L protein (15, 23, 24).
Using a panel of mutant PI proteins in which the phosphory-
lation sites in domain I were altered to alanines, we recently
showed that phosphorylation of these domain I residues is
necessary for the function of the P protein in transcription in
vivo (45). The replication functions of the P protein in vivo
were unaffected by the phosphorylation status of the domain I
residues. Based on these studies, it was proposed that an in-
crease in net negative charge in this region of the protein as a
result of phosphorylation is crucial for transcriptional activa-
tion of the P protein (45). However, in a separate study, low
levels (;25%) of transcription under in vitro conditions were
observed with a phosphorylation-defective P mutant protein
(52).
Phosphorylation of serine residues in domain II also seems
to control the activity of the P protein in RNA synthesis. It was
shown that phosphorylation of two specific residues (Ser-236
and Ser-242) in domain II of PNJ by L-associated kinase (LAK)
is necessary for in vitro transcription activity of the P protein
(11). For PNJ, domain I must be phosphorylated prior to LAK-
mediated phosphorylation of domain II residues (4). PI seems
to be different in this respect, since domain II residues can be
phosphorylated by LAK without prior phosphorylation of do-
main I residues (12). However, in a separate study, it was
shown that substitution of aspartic acid residues at S-60 and
T-62 in domain I of PI results in a protein that is not phos-
phorylated at other sites (24). Since phosphorylation in domain
I is necessary and sufficient for transcription, it appears that
phosphorylation of domain II residues may not be involved in
transcription (23, 40). In PI, the Ser-226 and Ser-233 residues
are homologous to Ser-236 and Ser-242 residues in PNJ and
were therefore proposed to be the potential sites of phosphor-
ylation (23). However, the actual sites of phosphorylation have
recently been mapped to Ser-226 and Ser-227 residues in PI
(12).
To examine the role of phosphorylation of domain II resi-
dues in the function of P protein in VSV RNA transcription
and replication in vivo, we have used a panel of mutant P
proteins with alanine substitutions at the phosphate acceptor
sites. Analysis of the mutant P proteins for their ability to
support replication of a VSV minigenomic template in vivo
showed that phosphorylation of the serine residue at either 226
or 227 is necessary for optimal replication activity of P protein.
In vivo-transcription activities of the mutant P proteins were
unaffected. Furthermore, substitution of negatively charged
glutamic acid residues for these serine residues resulted in a
protein that was only 14% as active as the wild-type protein in
replication while retaining almost full activity in transcription.
These results suggest that phosphorylation of domain II resi-
dues is required for optimal replication, but not for transcrip-
tion, function of the P protein.
MATERIALS AND METHODS
Cells and viruses. Growth and maintenance of baby hamster kidney (BHK-21)
cells (ATCC CCL10) have been described previously (46). VSV (Indiana sero-
type; San Juan strain) was grown, and infectivity titers were determined in
BHK-21 cells. The recombinant vaccinia virus (vTF7-3) containing the bacterio-
phage T7 RNA polymerase gene (22) was grown in BHK-21 cells, and infectivity
titers of stock vTF7-3 were determined as described earlier (45).
VSV protein- and minigenome-expressing plasmids. The plasmids encoding
the wild-type P protein (Pwt) or various mutant P proteins (P226, P227, P233,
P226/227, P226/233, P227/233, and P226/227/233) of VSV (Indiana serotype; Mudd-
Summers strain) in pET-3a vector have been described previously (12). These
mutant P proteins contain serine-to-alanine amino acid substitutions at positions
226, 227, 233, 226-227, 226-233, 227-233, and 226-227-233, respectively, within
domain II of the P protein (Fig. 1). The PEE mutant contains glutamic acid
residues in place of serine residues at positions 226 and 227 of wild-type P
protein. Plasmids pN and pL, carrying the coding regions for VSV (Indiana
serotype; San Juan strain) proteins N and L, respectively, under the control of
the T7 RNA polymerase promoter, have been reported before (46). Construc-
tion of the plasmid p9BN, encoding an antigenomic-sense VSV minigenome, has
also been described earlier (39).
Virus infections and DNA transfections. The details of the virus infection and
DNA transfection procedures have been described in our earlier publications
(44, 45). Briefly, BHK-21 cells in 60-mm-diameter plates or in 35-mm-diameter
six-well plates were grown to approximately 90% confluency. These cells were
infected with vTF7-3 at a multiplicity of infection of 10 PFU per cell. Following
virus adsorption at 37°C for 45 min, the cells were washed with serum-free
Dulbecco’s modified minimal essential medium (DMEM) and transfected with
various combinations of plasmid DNAs encoding the VSV proteins and the
minireplicon RNA by using Lipofectin reagent (Gibco/BRL, Gaithersburg, Md.)
or a transfection reagent prepared in the laboratory as described previously (8).
At 4 h posttransfection, the medium was removed from the transfected cells and
the cells were washed twice in DMEM supplemented with 2% fetal bovine serum
(FBS) and incubated at 37°C with an appropriate volume of the same medium
for different lengths of time before metabolic labeling with radioactive precur-
sors. Unless specifically described in the figure legends, in most experiments, 3
mg of pN, 2 mg of pET-3P, 1 mg of pL, and 5 mg of p9BN plasmids were used in
transfection of cells in 60-mm-diameter plates. These plasmid amounts were
reduced by half for cells in six-well plates.
Metabolic labeling and analysis of proteins. [35S]methionine labeling of pro-
teins in transfected cells, immunoprecipitation, and subsequent sodium dodecyl
sulfate-polyacrylamide gel analysis of the proteins have been described previ-
ously (45). P proteins were immunoprecipitated by using a rabbit anti-P (Indiana
serotype; Mudd-Summers strain) antibody.
Metabolic labeling and analysis of transcription and replication products.
Following incubation of transfected cells for 15 to 16 h at 37°C, the cells were
pretreated with 15 mg of actinomycin D per ml of DMEM plus FBS at 37°C for
FIG. 1. (A) Domain structure of the P protein of VSV (Indiana serotype).
The P protein with the three functionally defined domains (I, II, and III) and the
hinge region is shown. The phosphate acceptor sites (Ser-226, Ser-227, and
Ser-233) within domain II are represented by solid circles. (B) Various mutant P
proteins with substitutions of alanine (A) or glutamic acid (E) residues in place
of serine residues are shown.
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45 min. The cells were then labeled with 15 mCi of [3H]uridine and/or 15 mCi of
[3H]adenosine per ml of DMEM plus FBS containing actinomycin D. The la-
beling of RNAs was performed for 6 to 8 h at 37°C. Cytoplasmic extracts from
these cells were prepared in lysis buffer as described earlier (46). The labeled
RNA replication products in nucleocapsids were immunoprecipitated by poly-
clonal anti-VSV antibodies and recovered by extraction with phenol and chlo-
roform and precipitation with ethanol. The recovered RNAs were then separated
by electrophoresis in agarose-urea gels (38) and detected by fluorography (37) as
described in detail previously (46). For transcription analysis, total RNA from
the cytoplasmic extracts was purified by extraction with phenol and chloroform
and recovered by precipitation with ethanol. To generate VSV mRNAs, the cells
were infected with VSV at a multiplicity of infection of 10 and labeled with
[3H]uridine at 2 to 6 h postinfection in the presence of actinomycin D. Total
RNA was recovered from the cytoplasmic extracts. The RNAs were analyzed by
electrophoresis and fluorography as described above. The quantitation of repli-
cation and transcription product RNAs was carried out by densitometric scan-
ning of the fluorograms with an IS-1000 digital imaging system version 2.02
(Alpha Innotech Corporation, San Leandro, Calif.). The readout values from the
scanner provide integrated intensities of the appropriate bands in the fluoro-
grams. The relative levels of replication and transcription supported by various
mutants were calculated, with the values obtained for the wild-type P protein as
100. For normalization of levels of transcription supported by the mutant P
proteins, we used the following formula: normalized levels of transcription 5
relative levels of transcription/relative levels of replication 3 100.
RESULTS
The phosphorylation of serine residues at positions 236 and
242 within domain II of PNJ was shown previously to play a
major role in the function of P protein in transcription in vitro
(11). Based on amino acid sequence homology, corresponding
serine residues at positions 227 and 233 of PI were proposed to
be the potential sites for phosphorylation (23). Recently, how-
ever, biochemical and mutational studies identified serine res-
idues at positions 226 and 227 to be the sites of phosphoryla-
tion (12). To examine the role of phosphorylation of these
residues in P protein function in transcription and replication,
we used a series of mutant P proteins (Fig. 1B) in which serine
residues at positions 226, 227, and 233 were altered to alanines
either individually (in mutants P226, P227, and P233) or in var-
ious combinations (in mutants P226/227, P226/233, P227/233, and
P226/227/233). In initial experiments, we found that in trans-
fected cells, the mutant P proteins were expressed at levels
similar to that of the wild-type P protein and the amount of P
protein expression was roughly proportional to the amount of
plasmid transfected into the cells within a range of 1 to 15 mg.
Furthermore, in pulse-chase experiments, the mutant proteins
were stable over an 8-h chase period (data not shown).
In our earlier studies, we showed that the wild-type P protein
of the Mudd-Summers strain of VSV functions as well as the
San Juan strain of VSV P protein in transcription and repli-
cation with San Juan N and L proteins (45); therefore, the
above-mentioned mutant P proteins of the Mudd-Summers
strain were used in order to test their abilities to support
transcription and replication in the presence of the N and L
proteins of San Juan VSV.
Phosphorylation-defective mutant P proteins do not support
optimal replication of VSV. To examine the ability of the
mutant P proteins to support replication of a VSV minig-
enome, we used a plasmid encoding an antigenomic-sense
VSV minireplicon (9BN) RNA (39). The minireplicon RNA
contains the terminal sequences of the VSV antigenome flank-
ing the sequences of the N gene and part of the L gene (39). In
cells transfected with the plasmid along with the plasmids en-
coding the viral proteins N, P, and L, the antigenomic-sense
minireplicon RNA is replicated and amplified to generate the
genomic- and antigenomic-sense RNAs (39). However, the
genomic-sense RNA replication products can be more readily
detected by metabolic labeling of the transfected cells, since
the genomic RNAs are synthesized in much greater molar
abundance than the antigenomic-sense RNAs. To perform the
experiment, BHK-21 cells infected with vTF7-3 were trans-
fected with plasmids encoding the minireplicon and N, L, and
the wild-type or mutant P proteins. [3H]uridine- and [3H]ade-
nosine-labeled RNAs synthesized in the presence of actinomy-
cin D were recovered from immunoprecipitated nucleocapsids
and analyzed by electrophoresis. The results (Fig. 2) from a
typical experiment show that the mutant P proteins P226, P227,
P233, P226/233, and P227/233 (Fig. 2, lanes 4 to 6, 8, and 9) were
as active as the wild-type P protein (Fig. 2, lane 3) in replica-
tion, since the amounts of replication product obtained with
the mutant proteins were comparable to that of the wild-type
P protein. However, the replication activities of the mutant
proteins P226/227 (Fig. 2, lane 7) and P226/227/233 (lane 10) were
significantly less than that of the wild-type P protein. In three
to five independent experiments, the average replication activ-
ity of P226/227 and P226/227/233 mutants was found to be 8 and
13%, respectively (Table 1; also see Fig. 5) of that of the
wild-type protein.
We also examined whether it is possible to rescue higher
levels of replication with increasing or decreasing amounts of
P226/227 in transfected cells. Initially, we determined the
amounts of the Pwt and P226/227 proteins synthesized in cells
transfected with various amounts of the corresponding plas-
mids. We found that the wild-type and mutant proteins were
synthesized in equivalent amounts, and a linear relationship
was found to exist between the amounts of the expressed pro-
teins and the amounts of the corresponding plasmid DNA used
in transfection (Fig. 3A and 3B). When the levels of replication
with various amounts of P226/227 were examined, it was found
that the levels of replication increased as the amount of P226/
227 plasmid was increased and reached a maximum with 2 mg of
the plasmid (Fig. 3C, lane 4). However, this level represented
only 8% of that obtained with 2 mg of the plasmid encoding the
wild-type protein (Fig. 2 and Table 1). The results (Fig. 3C)
indicated that higher levels of replication could not be rescued
with altered amounts of P226/227 protein. These results suggest
that substitution of alanine for serine residues at 226 and 227
renders the protein significantly less active in replication and
that serine residue at position 233 may not have a role in the
replication activity of the protein. Since the serine residues at
both 226 and 227 have been shown to be phosphorylated (12),
FIG. 2. Replication of a VSV antigenomic minireplicon with P mutants.
BHK-21 cells in 60-mm-diameter plates were infected with vTF7-3 and trans-
fected with plasmids encoding the minigenomic RNA and the N, L, and wild-type
or mutant P proteins. At 16 h posttransfection, the cells were labeled with
[3H]uridine and [3H]adenosine in the presence of actinomycin D for 6 h. The
replicated RNAs were recovered by immunoprecipitation and analyzed by elec-
trophoresis. The arrow indicates the negative-sense replication product. The
asterisk shows the transcription product which is sometimes nonspecifically im-
munoprecipitated by anti-VSV antibodies. G and N at left represent the G
mRNA and N mRNA of VSV isolated from infected cells labeled with [3H]uri-
dine.
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the results further suggest that phosphorylation of the serine
residue at either 226 or 227 is sufficient to achieve optimal
replication activity of the protein.
Taken together, these results suggest that at least one of the
serine residues at positions 226 and 227 must be phosphory-
lated to obtain optimal replication activity of the P protein. In
addition, the results indicate that Ser-233 does not play any
role in the replication function of the P protein, consistent with
the observation that this residue is not phosphorylated (12).
Transcription activity of the mutant P proteins remains
unaffected. We next examined the ability of these mutant pro-
teins to support transcription in vivo. BHK-21 cells infected
with vTF7-3 were transfected with plasmids encoding 9BN
minireplicon RNA and N, L, and wild-type or mutant P pro-
teins. The transfected cells were then labeled with [3H]uridine
and [3H]adenosine in the presence of actinomycin D. Total
labeled RNAs isolated from these cells were analyzed by elec-
trophoresis. Synthesis of NDL mRNA (Fig. 4) was used as a
measure of the transcription activity of the mutant P proteins.
The results (Fig. 4) show that P226, P227, P233, P226/233, and
P227/233 (lanes 4 to 6, 8, and 9) are almost as active as the
wild-type P protein (lane 3) in transcription. However, the
amount of NDL mRNA synthesized by the P226/227 (lane 7) and
P226/227/233 (lane 10) mutants was significantly reduced. A
quantitative determination of the levels of transcription sug-
gests that the P226/227 and P226/227/233 mutants were 8 and 12%,
respectively, as active as the wild-type protein (Table 1).
Since the genomic-sense transcription template in our ex-
periment is generated through replication of an antigenomic-
sense minireplicon synthesized from the transfected plasmid,
the low level of transcription by P226/227 and P226/227/233 mu-
tants appears to be due to low levels of transcription template
generated by these mutants (Fig. 2, lanes 7 and 10, and Table
1). To obtain a more accurate estimation of the relative levels
of transcription activity of these mutants, we normalized the
levels of transcription relative to the levels of replication as
described in Materials and Methods. In a separate experiment,
we first established that the amount of transcription, as mea-
sured by the synthesis of NDL mRNA, directly correlated with
the amount of genomic-sense transcription template in trans-
fected cells. In this experiment, vTF7-3-infected cells were
transfected with varying amounts of plasmids encoding the
minireplicon RNA along with fixed amounts of plasmids en-
coding the N, L, and wild-type P proteins. The cells were
metabolically labeled with [3H]uridine and [3H]adenosine in
the presence of actinomycin D. Replication products (RNAs
recovered from immunoprecipitated nucleocapsids) and tran-
scription products were analyzed by electrophoresis and fluo-
rography and quantitated by densitometric scanning of the
FIG. 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis
of immunoprecipitated wild-type (A) and P226/227 (B) proteins expressed in cells
transfected with various amounts (indicated in micrograms above each lane) of
the plasmids. The expressed proteins are shown by the arrows in these panels.
(C) Replication of VSV minireplicon RNA in the presence of various amounts
(indicated in micrograms above each lane) of transfected P226/227 plasmid. Anal-
ysis of replication was performed as described in the legend to Fig. 2. The arrow
indicates the negative-sense replication product. The asterisk shows the tran-
scription product which is sometimes nonspecifically immunoprecipitated by
anti-VSV antibodies.
FIG. 4. Transcription activity of P mutants. BHK-21 cells in 35-mm-diameter
six-well plates were infected with vTF7-3 and then transfected with 1.5 mg of pN,
0.5 mg of pL, 2.5 mg of p9BN, and 1.0 mg of pET-P plasmids coding for the
wild-type or mutant P proteins. The transfected cells were labeled with [3H]uri-
dine and [3H]adenosine at 16 h posttransfection for 6 h in the presence of
actinomycin D. Total RNA from the cytoplasmic extracts was recovered and
analyzed by electrophoresis as described in Materials and Methods. G and N
represent the corresponding VSV mRNAs isolated from infected cells. The
asterisk shows the NDL RNA transcription product.
TABLE 1. Relative levels of replication and transcription by various mutant P proteinsa
P Protein Replicationb Relative replication (%) Transcriptionb Relative transcription (%) Normalized transcription (%)c
Pwt 149,535 100 273,961 100 100
P226 148,183 99 265,748 97 98
P227 151,218 101 268,873 98 97
P233 152,562 102 257,498 94 92
P226/227 12,177 8 21,449 7.8 97
P226/233 146,783 98 267,902 98 100
P227/233 142,374 95 265,835 97 102
P226/227/233 19,132 13 33,589 12.3 95
a Relative levels of replication and transcription were calculated with wild-type levels as 100.
b Average values from densitometric scanning of fluorograms of four independent experiments. Note that replication and transcription gels were exposed for different
lengths of time.
c Normalized levels of transcription were calculated as described in Materials and Methods.
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fluorograms as described in Materials and Methods. The re-
sults (not shown) demonstrated a linear relationship between
the genomic-sense replication product (or transcription tem-
plate) and the transcription product. When the normalized
levels of transcription for various mutant P proteins were cal-
culated, it was found that all the mutant proteins supported
levels of transcription comparable to that of the wild-type P
protein (Fig. 5). These results were consistently obtained in
four to five independent experiments. We conclude from these
studies that phosphorylation of serine residues at positions 226
and/or 227 in domain II of the P protein do not play a role in
the transcription functions of the protein.
Substitution of glutamic acid at the phosphate acceptor
sites does not rescue optimal replication functions of P pro-
tein. One of the consequences of phosphorylation of amino
acid residues in a protein is the introduction of negative
charges. We wondered whether phosphorylation per se of the
Ser-226 and Ser-227 residues of P protein is essential for op-
timal replication functions of the protein or whether substitu-
tion of negatively charged residues in place of these serine
residues can generate replicationally active P protein. To ad-
dress this possibility, we generated a mutant P protein (PEE) in
which serine residues at positions 226 and 227 were replaced
with glutamic acid residues. The ability of the mutant protein
to support replication of the VSV minigenome was analyzed.
The results (Fig. 6A) show that the PEE mutant (lane 5) is
slightly more active in replication than the analine-substituted
mutant protein (lane 4). However, the level of replication
supported by PEE is only 12 to 14% of that of the wild-type
protein (lane 3). When the transcription activity of these mu-
tant proteins was measured, PEE consistently produced slightly
higher levels of NDL mRNA (Fig. 6B, lane 5) than P226/227
(lane 4). This is most likely due to higher levels of transcription
templates generated by the PEE mutant than the P226/227 mu-
tant. When the level of transcription was normalized to the
amount of transcription template, PEE was found to be about
90 to 95% as active as the wild-type P protein (Fig. 5).
These results (Fig. 6) suggest that substitution of negatively
charged (glutamic acid) residues at the phosphate acceptor
sites does not rescue the optimal replication activity of the P
protein. This indicates that phosphorylation of these residues
rather than negative charges in this region is important for the
function of P protein in replication. The observation that PEE
was almost as active as P226/227 or wild-type P in transcription
further confirms that phosphorylation of these residues does
not play any role in P protein function in transcription.
P226/227 mutant protein acts as an inhibitor of wild-type P
protein in replication. We next wanted to determine whether
the P226/227 mutant, which is defective in supporting optimal
levels of replication, when coexpressed along with the wild-
type protein, can interfere with the normal functioning of the
wild-type protein in replication. To examine this, replication of
the VSV minigenome in transfected cells coexpressing various
amounts of Pwt and P226/227 proteins was analyzed. The results
from such an experiment (Fig. 7) show that coexpression of a
fixed amount of Pwt and varying amounts of P226/227 (lanes 6 to
8) led to significant inhibition of minigenome replication. It
must be noted that increasing the amounts of Pwt or P226/227 led
to inhibition of minigenome replication (data not shown), most
likely due to imbalance in the molar amounts of the viral
proteins required for replication (46). However, the inhibitory
activity of P226/227 is clearly evident when one compares levels
of replication supported by a given amount of Pwt with that
supported by the same amount of both Pwt and P226/227. The
amount of replication with 4 mg of total plasmids (2 mg each of
Pwt and P226/227) (Fig. 7, lane 7) was approximately one-third of
that obtained with 4 mg of Pwt plasmid alone (lane 3). Likewise,
the amount of replication with 6 mg of total plasmids (2 mg of
Pwt and 4 mg of P226/227) (Fig. 7, lane 8) was approximately
one-fourth of that obtained with 6 mg of Pwt plasmid alone
FIG. 5. Relative levels of replication and normalized levels of transcription
supported by various mutant P proteins. The data were obtained by densitomet-
ric scanning of fluorograms as described in Materials and Methods. The histo-
grams represent data from four to five separate experiments, including those
shown in Fig. 2, 4, and 6. The average and range of each value are shown.
FIG. 6. Replication (A) and transcription (B) supported by PEE. These ex-
periments were performed as described in the legend to Fig. 2 and 4. The arrow
in panel A and the asterisk in panel B show the replication and transcription
products, respectively.
FIG. 7. Inhibitory activity of P226/227 in replication when coexpressed with
wild-type P. The value above each lane indicates the amount (in micrograms) of
each P plasmid used in the transfection. The experiment was performed as
described in the legend to Fig. 2. The arrow shows the replication product.
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(lane 4). In addition, when 2 mg of Pwt plasmid was used along
with increasing amounts of P226/227, significant inhibition of
replication was observed (compare the levels of replication in
Fig. 7, lane 2, with those in lanes 6 to 8). These results, there-
fore, indicate that P226/227 protein inhibits the function of Pwt
protein in replication in vivo.
DISCUSSION
The phosphoprotein (P) of VSV plays a central role in the
transcription and replication functions of the RNA-dependent
RNA polymerase of the virion. Although the P protein does
not carry any enzymatic activities of the viral polymerase, its
interaction with the large protein, L, generates a specific P-L
complex(es) which is absolutely essential for the polymerase
activity. The P protein interacts with soluble N protein to form
N-P complexes that are required for encapsidation of nascent
RNA chains during replication. P protein is known to exist as
oligomers, and oligomerization of P protein appears to be
required for interaction with the L protein to generate tran-
scription activity of the P-L complex. In addition, the P protein
exists in multiple phosphorylated forms within the virion core
as well as in infected cells, and phosphorylation of residues
within specific domains of the P protein regulates its RNA-
synthetic activities. Because of the multifunctional nature of
the P protein, a great deal of investigation has been directed
towards understanding its structure-function relationships.
We and others have shown recently that phosphorylation of
specific residues within domain I of P protein of Indiana sero-
type VSV is not essential for the in vivo replication function of
the protein (45, 52). However, in vivo transcription activity of
the protein required phosphorylation of the residues in this
domain (45), although low levels of in vitro transcription ac-
tivity were obtained with domain I phosphorylation-defective P
protein (52). In the present work, we have examined the role of
phosphorylation of domain II residues in in vivo transcription
and replication activities of the protein. Our results suggest
that phosphorylation of a specific serine residue(s) (Ser-226 or
Ser-227) in this domain is required for optimal replication
activity of the protein. Interestingly, transcription activity of
the protein was not adversely affected by the phosphorylation
status of the domain II residues. The major conclusion that can
be drawn from our studies is that phosphorylation at two dif-
ferent domains in the P protein of VSV regulates its activity in
transcription and replication. However, it must be pointed out
that the requirement for phosphorylation of domain I residues
in transcription could be overcome by substitution of nega-
tively charged residues for serine residues (24, 45) whereas
appreciable levels of replication could not be rescued by sub-
stitution of glutamic acid residues for serine residues in do-
main II (Fig. 6). These results may suggest a unique role of
phosphorylation in the function of the P protein in replication
but not in transcription.
Recently, it was demonstrated (23) that serine residues at
positions 227 and 233 within domain II of PI are the major
targets of phosphorylation by LAK. However, in a separate
study, it was shown by mutational and biochemical analyses
that serine residues at 226 and 227 are the sites of phosphor-
ylation by LAK (12). The reason(s) for this discrepancy is not
clear at this time but the results of our functional analysis of
the mutant P proteins, in which each of these three sites was
altered to alanine individually or in various combinations, in-
dicate that Ser-233 does not appear to play any role in tran-
scription or replication functions of the protein. Our results are
consistent with those reported earlier from in vitro-transcrip-
tion studies, suggesting that phosphorylation of domain II res-
idues by LAK has no role in the transcription activity of PI (23,
40). These results appear to conflict with those obtained pre-
viously, which showed that phosphorylation of Ser-236 and
Ser-242 in domain II of PNJ by LAK is necessary for efficient
transcription in vitro (11). It is possible that the activity of the
mutant proteins differs under in vivo and in vitro conditions, as
has been demonstrated recently with domain I phosphoryla-
tion-defective P mutant proteins (45, 52). Alternatively, it is
possible that the functional requirement for phosphorylation
of domain II residues of PNJ may be different from that of PI.
This may be borne out by the observation that phosphorylation
of domain I residues of PNJ is a prerequisite for phosphoryla-
tion of domain II residues (4) whereas domain II of PI can be
phosphorylated without prior phosphorylation of domain I res-
idues (12).
The observation that domain II phosphorylation-defective P
protein is defective in replication but not in transcription in-
dicates that phosphorylation of domain II residues may be
important for formation of replicase complexes. We recently
suggested that the replicase complex of VSV may exist as a
tripartite complex consisting of the N, P, and L proteins (16)
and that other cellular factors may also be present in the
replicase complex (26). It is possible that phosphorylation of
domain II residues results in a conformation that facilitates
specific interaction with the L and/or N protein for assembly of
the replicase complex. The P protein, lacking phosphates in
domain II residues, may interact poorly with the other viral
proteins so that low levels of replication complexes are formed
or that the replication complexes are less active. It is obviously
important to examine the interaction of the mutant P proteins
with the N and L proteins to understand how phosphorylation
in domain II of P might influence the assembly and activity of
the replicase complex. It must be noted here that the mutant
protein (P227/233) multimerized and interacted well with the L
protein (23). However, the data should be considered in the
context that this mutant protein was phosphorylated at Ser-226
(12).
Several recent studies have provided a correlation between
the degree of phosphorylation of the P protein and its activity
in transcription and replication. Using okadaic acid, a serine/
threonine phosphatase inhibitor, it was shown that the hyper-
phosphorylated form of the P protein (presumably having
phosphates in both domain I and II residues) inhibited repli-
cation (10). Conversely, dephosphorylation of P protein by
bacterial alkaline phosphatase (BAP) led to increased genome
replication, with a concomitant decrease in transcription (49).
The amount of BAP needed to stimulate genome replication
and inhibit transcription was substantially below that needed to
obtain a noticeable increase in reactivity to a monoclonal an-
tibody (6D11) directed against an epitope that maps to resi-
dues 177 to 227 of the P protein (49, 55), corresponding to part
of domain II. Although these studies did not map the sites
from which phosphate moieties were removed by BAP treat-
ment, they indicated that the epitope bound by 6D11 antibody
is changed by dephosphorylation (49). Since treatment of in-
fected-cell P protein with BAP increased genome replication
and inhibited transcription without a noticeable increase in
6D11 antibody reactivity, these results indicate that BAP may
have removed phosphates only from domain I residues. These
observations, together with our previous results (45) and the
data presented here, suggest that the P1 protein, with phos-
phorylation of domain I residues, may function as part of a
transcription complex whereas the P2 protein, with phosphor-
ylation of residues in domain II, may function exclusively as
part of a replication complex. Another subset of P proteins
(hyperphosphorylated P2 protein with phosphorylation of both
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domain I and II residues) may be involved in maturation of
nucleocapsids for packaging and thereby indirectly inhibit rep-
lication (10). Further studies focusing on isolation of com-
plexes specific for transcription and replication and examina-
tion of the phosphorylation status of P protein in these
complexes may provide more direct evidence as to the role of
phosphorylation of residues in various domains in transcription
and replication.
The inhibitory activity of P226/227 in replication by wild-type
P protein (Fig. 7) indicates that the domain II phosphoryla-
tion-defective P protein perhaps interacts with the other com-
ponents of the replication machinery to generate inactive com-
plexes or competes with the wild-type P protein for replication
machinery. Studies to examine specific interactions of the mu-
tant protein with the N, L, or N-RNA template may provide a
better understanding of the inhibitory effect of the mutant
protein in replication.
The phosphate acceptor sites (Ser-226 and Ser-227) within
domain II are located adjacent to each other, and our results
(Fig. 2) show that phosphorylation of either of these two res-
idues is sufficient to obtain optimal replication activity of the
protein. Furthermore, previous data indicate that phosphory-
lations at these sites are independent of each other (12). The
question then is why two functionally redundant phosphoryla-
tion sites are maintained in the protein. It is possible that in a
given P molecule, only one of these two sites is phosphorylated
in vivo and the other site may remain unphosphorylated be-
cause of steric hindrance. Alternatively, the presence of two
functionally redundant phosphorylation sites next to each
other may protect the protein from becoming inactivated in
replication by phosphatases, which must remove both of the
phosphate moieties at the same time.
In summary, the results reported in this article suggest that
phosphorylation of either the Ser-226 or Ser-227 residue in
domain II is necessary for optimal replication activity, but not
for transcription activity, of the P protein. Substitution of neg-
atively charged residues for these residues cannot rescue rep-
lication. From these results and those reported previously (10,
23, 24, 45, 49, 52), we conclude that phosphorylation within
different domains of the P protein controls its activity in tran-
scription and replication. Studies of infectious molecular
clones of VSV containing various phosphorylation-defective
mutants of P protein may provide additional information as to
the role of this modification in the RNA-synthetic processes of
VSV. In several other negative-strand RNA viruses, the P
protein has been found to be phosphorylated (5, 7, 14, 17, 19,
42, 43, 54), and the functional significance of phosphorylation
in transcription has also been documented (5, 7, 17, 42).
Whether transcriptase and replicase activities are regulated by
differential phosphorylation of the P proteins of these viruses
remains to be examined.
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